hVIVO, Solvonis Therapeutics, Genel Energy, Active Energy, Pantheon Intl - Small Cap Snapshot

hVIVO is set to run the world's first Phase 3 human challenge trial for a new whooping cough vaccine. Scheduled for late 2025, ...